Overview
8p23.1 microdeletion syndrome (also known as chromosome 8p23.1 deletion syndrome or monosomy 8p23.1) is a rare chromosomal disorder caused by a submicroscopic deletion on the short arm of chromosome 8 at band p23.1. This region contains several important genes, including GATA4, which plays a critical role in heart development. As a result, congenital heart defects — particularly atrioventricular septal defects (AVSD), atrial septal defects, and other structural cardiac anomalies — are among the most prominent features of this syndrome. The deletion can occur de novo or may be inherited from a carrier parent who harbors a balanced rearrangement (such as an inversion) involving the 8p23.1 region. Affected individuals typically present with intellectual disability ranging from mild to moderate, developmental delay, speech and language difficulties, and behavioral problems including features overlapping with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder. Characteristic facial features may include a high and broad forehead, arched eyebrows, a short nose with a broad nasal bridge, low-set ears, and a thin upper lip. Additional findings can include microcephaly, diaphragmatic hernia (particularly congenital diaphragmatic hernia, or CDH), and growth restriction. There is no cure for 8p23.1 microdeletion syndrome, and management is supportive and symptom-based. Congenital heart defects often require surgical correction. Early intervention programs including speech therapy, occupational therapy, and special educational support are recommended to optimize developmental outcomes. Behavioral and psychological support may also be beneficial. Regular follow-up with a multidisciplinary team including cardiologists, developmental pediatricians, and geneticists is important for comprehensive care.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 8p23.1 microdeletion syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 8p23.1 microdeletion syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 8p23.1 microdeletion syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 8p23.1 microdeletion syndrome.
Community
No community posts yet. Be the first to share your experience with 8p23.1 microdeletion syndrome.
Start the conversation →Latest news about 8p23.1 microdeletion syndrome
No recent news articles for 8p23.1 microdeletion syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 8p23.1 microdeletion syndrome
What is 8p23.1 microdeletion syndrome?
8p23.1 microdeletion syndrome (also known as chromosome 8p23.1 deletion syndrome or monosomy 8p23.1) is a rare chromosomal disorder caused by a submicroscopic deletion on the short arm of chromosome 8 at band p23.1. This region contains several important genes, including GATA4, which plays a critical role in heart development. As a result, congenital heart defects — particularly atrioventricular septal defects (AVSD), atrial septal defects, and other structural cardiac anomalies — are among the most prominent features of this syndrome. The deletion can occur de novo or may be inherited from a
At what age does 8p23.1 microdeletion syndrome typically begin?
Typical onset of 8p23.1 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.